These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1092 related articles for article (PubMed ID: 15940625)

  • 1. Sampling variability of liver biopsy in nonalcoholic fatty liver disease.
    Ratziu V; Charlotte F; Heurtier A; Gombert S; Giral P; Bruckert E; Grimaldi A; Capron F; Poynard T;
    Gastroenterology; 2005 Jun; 128(7):1898-906. PubMed ID: 15940625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of liver biopsy sample length and number of readings on sampling variability in nonalcoholic Fatty liver disease.
    Vuppalanchi R; Unalp A; Van Natta ML; Cummings OW; Sandrasegaran KE; Hameed T; Tonascia J; Chalasani N
    Clin Gastroenterol Hepatol; 2009 Apr; 7(4):481-6. PubMed ID: 19162235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sampling error in histopathology findings of nonalcoholic fatty liver disease: a post mortem liver histology study.
    Merat S; Sotoudehmanesh R; Nouraie M; Peikan-Heirati M; Sepanlou SG; Malekzadeh R; Sotoudeh M
    Arch Iran Med; 2012 Jul; 15(7):418-21. PubMed ID: 22724878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathologic criteria for nonalcoholic steatohepatitis: interprotocol agreement and ability to predict liver-related mortality.
    Younossi ZM; Stepanova M; Rafiq N; Makhlouf H; Younoszai Z; Agrawal R; Goodman Z
    Hepatology; 2011 Jun; 53(6):1874-82. PubMed ID: 21360720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generalizability of the nonalcoholic steatohepatitis Clinical Research Network histologic scoring system for nonalcoholic fatty liver disease.
    Juluri R; Vuppalanchi R; Olson J; Unalp A; Van Natta ML; Cummings OW; Tonascia J; Chalasani N
    J Clin Gastroenterol; 2011 Jan; 45(1):55-8. PubMed ID: 20505526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of liver biopsy heterogeneity and diagnosis of nonalcoholic steatohepatitis in subjects undergoing gastric bypass.
    Arun J; Jhala N; Lazenby AJ; Clements R; Abrams GA
    Obes Surg; 2007 Feb; 17(2):155-61. PubMed ID: 17476865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histopathologic variability between the right and left lobes of the liver in morbidly obese patients undergoing Roux-en-Y bypass.
    Larson SP; Bowers SP; Palekar NA; Ward JA; Pulcini JP; Harrison SA
    Clin Gastroenterol Hepatol; 2007 Nov; 5(11):1329-32. PubMed ID: 17702661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histopathology, grading and staging of nonalcoholic fatty liver disease.
    Kleiner DE
    Minerva Gastroenterol Dietol; 2018 Mar; 64(1):28-38. PubMed ID: 28948754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of paired liver biopsies in morbidly obese patients with suspected nonalcoholic fatty liver disease.
    Merriman RB; Ferrell LD; Patti MG; Weston SR; Pabst MS; Aouizerat BE; Bass NM
    Hepatology; 2006 Oct; 44(4):874-80. PubMed ID: 17006934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
    Takahashi Y; Fukusato T
    World J Gastroenterol; 2014 Nov; 20(42):15539-48. PubMed ID: 25400438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Role of liver biopsy in the diagnosis of NASH].
    Kanemasa K; Sumida Y
    Nihon Rinsho; 2006 Jun; 64(6):1119-25. PubMed ID: 16768119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-Throughput, Machine Learning-Based Quantification of Steatosis, Inflammation, Ballooning, and Fibrosis in Biopsies From Patients With Nonalcoholic Fatty Liver Disease.
    Forlano R; Mullish BH; Giannakeas N; Maurice JB; Angkathunyakul N; Lloyd J; Tzallas AT; Tsipouras M; Yee M; Thursz MR; Goldin RD; Manousou P
    Clin Gastroenterol Hepatol; 2020 Aug; 18(9):2081-2090.e9. PubMed ID: 31887451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histopathological stages of nonalcoholic fatty liver disease in type 2 diabetes: prevalences and correlated factors.
    Leite NC; Villela-Nogueira CA; Pannain VL; Bottino AC; Rezende GF; Cardoso CR; Salles GF
    Liver Int; 2011 May; 31(5):700-6. PubMed ID: 21457442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions.
    Brunt EM; Janney CG; Di Bisceglie AM; Neuschwander-Tetri BA; Bacon BR
    Am J Gastroenterol; 1999 Sep; 94(9):2467-74. PubMed ID: 10484010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-alcoholic steatohepatitis in children.
    Nanda K
    Pediatr Transplant; 2004 Dec; 8(6):613-8. PubMed ID: 15598336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic value of serum prolidase enzyme activity to predict the liver histological lesions in non-alcoholic fatty liver disease: a surrogate marker to distinguish steatohepatitis from simple steatosis.
    Kayadibi H; Gültepe M; Yasar B; Ince AT; Ozcan O; Ipcioglu OM; Kurdas OO; Bolat B; Benek YZ; Guveli H; Atalay S; Ozkara S; Keskin O
    Dig Dis Sci; 2009 Aug; 54(8):1764-71. PubMed ID: 18989777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and validation of a histological scoring system for nonalcoholic fatty liver disease.
    Kleiner DE; Brunt EM; Van Natta M; Behling C; Contos MJ; Cummings OW; Ferrell LD; Liu YC; Torbenson MS; Unalp-Arida A; Yeh M; McCullough AJ; Sanyal AJ;
    Hepatology; 2005 Jun; 41(6):1313-21. PubMed ID: 15915461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reliability of the nonalcoholic steatohepatitis clinical research network and steatosis activity fibrosis histological scoring systems.
    Leung HH; Puspanathan P; Chan AW; Nik Mustapha NR; Wong VW; Chan WK
    J Gastroenterol Hepatol; 2022 Jun; 37(6):1131-1138. PubMed ID: 35362158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonalcoholic steatohepatitis: definition and pathology.
    Brunt EM
    Semin Liver Dis; 2001; 21(1):3-16. PubMed ID: 11296695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of liver biopsy to assess non-alcoholic fatty liver disease.
    Kobyliak N; Abenavoli L
    Rev Recent Clin Trials; 2014; 9(3):159-69. PubMed ID: 25514908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 55.